Published in
Taylor and Francis Group, Expert Opinion on Therapeutic Patents, 3(31), p. 223-238, 2020
DOI: 10.1080/13543776.2021.1860210
Links
Tools
Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors for the treatment of non-small cell lung cancer: a patent review (2014-present)
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 